International Biological Reference Preparations for Epidemic Infectious Diseases.
Ebola virus disease
Middle East respiratory syndrome coronavirus
World Health Organization
biological standardization
bioterrorism and preparedness
emerging infectious diseases
epidemic preparedness
global health security
infectious diseases
reference preparations
research and development
vaccines
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
entrez:
23
1
2019
pubmed:
23
1
2019
medline:
30
7
2019
Statut:
ppublish
Résumé
Recent years have seen unprecedented investment in research and development for countermeasures for high-threat pathogens, including specific and ambitious objectives for development of diagnostics, therapeutics, and vaccines. The inadequate availability of biological reference materials for these pathogens poses a genuine obstacle in pursuit of these objectives, and the lack of a comprehensive and equitable framework for developing reference materials is a weakness. We outline the need for internationally standardized biological materials for high-threat pathogens as a core element of global health security. We also outline the key components of a framework for addressing this deficiency.
Identifiants
pubmed: 30666925
doi: 10.3201/eid2502.180798
pmc: PMC6346470
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Langues
eng
Pagination
205-211Références
Front Microbiol. 2017 Aug 03;8:1469
pubmed: 28824594
Lancet. 2017 Nov 11;390(10108):2211-2214
pubmed: 28577861
J Clin Microbiol. 1998 Dec;36(12):3590-4
pubmed: 9817878
Expert Opin Investig Drugs. 2016 Nov;25(11):1325-1335
pubmed: 27676206
Hum Vaccin Immunother. 2015;11(6):1351-6
pubmed: 25970793
Pharmacology. 2008;82(3):171-9
pubmed: 18679046
Lancet Infect Dis. 2016 Jan;16(1):31-42
pubmed: 26546548
N Engl J Med. 2016 Apr 28;374(17):1635-46
pubmed: 25629663
PLoS Med. 2016 May 19;13(5):e1002042
pubmed: 27195954
Biologicals. 1991 Jul;19(3):161-9
pubmed: 1953999
Lancet. 2017 Feb 11;389(10069):621-628
pubmed: 28017399
Sci Rep. 2016 Apr 25;6:24897
pubmed: 27109916
PLoS Negl Trop Dis. 2016 Oct 27;10(10):e0004948
pubmed: 27788135
N Engl J Med. 2017 Jan 26;376(4):330-341
pubmed: 25830322
Dev Biol Stand. 1999;100:11-5
pubmed: 10616171
Vaccine. 2018 Aug 28;36(36):5454-5459
pubmed: 28780120
JAMA. 2017 Apr 4;317(13):1381
pubmed: 28384815
PLoS Med. 2010 May 04;7(5):e1000247
pubmed: 20454566
PLoS One. 2015 Nov 12;10(11):e0142751
pubmed: 26562415
Clin Microbiol Infect. 2014 Jun;20(6):507-15
pubmed: 24909400
JAMA. 2016 Apr 19;315(15):1610-23
pubmed: 27092831
J Clin Microbiol. 2016 Apr;54(4):860-7
pubmed: 26888897
Lancet. 2016 Jul 30;388(10043):460-1
pubmed: 27507751
J Infect Public Health. 2018 Jan - Feb;11(1):9-17
pubmed: 28864360
Lancet. 2017 Feb 4;389(10068):505-518
pubmed: 28017403
J Virol Methods. 2014 Nov;208:33-40
pubmed: 25072380
PLoS Pathog. 2013 Jan;9(1):e1003105
pubmed: 23349630
Hum Reprod. 1997 Sep;12(9):2076-80
pubmed: 9363733
Nat Med. 2016 Jul 7;22(7):701-5
pubmed: 27387881
JAMA. 2011 Jul 13;306(2):200-1
pubmed: 21750298
N Engl J Med. 2016 May 12;374(19):1801-3
pubmed: 27028782
Euro Surveill. 2018 May;23(19):
pubmed: 29766839
Br Med J. 1894 Oct 27;2(1765):931-3
pubmed: 20755144
Vaccine. 2017 Mar 1;35(9):1347-1352
pubmed: 28161420
N Engl J Med. 2016 Oct 13;375(15):1448-1456
pubmed: 27732819
N Engl J Med. 2016 Jan 7;374(1):33-42
pubmed: 26735992
Emerg Infect Dis. 2016 Sep;22(9):1554-61
pubmed: 27532807
J Microbiol. 2017 Mar;55(3):172-182
pubmed: 28243939
Hum Vaccin Immunother. 2017 Dec 2;13(12):2755-2762
pubmed: 28375764